ELEVATED LP(A)

Clinical trials for ELEVATED LP(A) explained in plain language.

Never miss a new study

Get alerted when new ELEVATED LP(A) trials appear

Sign up with your email to follow new studies for ELEVATED LP(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Massive heart trial targets hidden fat risk factor

Disease control Ongoing

This large Phase 3 study tests an injectable drug called lepodisiran in about 17,300 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants either already have heart disease or are at high risk for a first heart attack or stroke. The goal…

Matched conditions: ELEVATED LP(A)

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated May 11, 2026 20:53 UTC

ELEVATED LP(A)

Get alerted when new ELEVATED LP(A) trials appear

Massive heart trial targets hidden fat risk factor